naturalX Health Ventures advises on a €100 million investment in Function Health during a $298 million Series B funding round, valuing the company at $2.5 billion.

Target Information

Function Health is pioneering a groundbreaking preventive health model aimed at consumers, designed to enhance personal health management through innovative technology. Central to its offerings is a comprehensive panel of over 160 biomarkers that provide users with valuable insights into their metabolic, hormonal, cardiovascular, and immunological health. This proactive approach enables early detection of health risks that might otherwise go unnoticed, empowering individuals to take charge of their health.

Building on its initial success, Function Health has unveiled its 'Medical Intelligence Lab', which leverages artificial intelligence to integrate laboratory results, imaging, wearable devices, medical records, and global research into a dynamic and personalized health model. This advanced system continuously learns and identifies patterns, translating them into actionable health recommendations tailored for each user.

Industry Overview

Function Health operates within the thriving consumer health industry, which has seen significant growth as individuals increasingly prioritize preventive health solutions. The industry is evolving rapidly, driven by advancements in technolog

View Source

Similar Deals

AIF, PMV and QBIC III Animab

2025

Series B Bio Therapeutic Drugs Other
Lapam Capital Epigenic Therapeutics

2025

Series B Bio Therapeutic Drugs Other
Angelini Ventures NUCLIDIUM

2025

Series B Proprietary & Advanced Pharmaceuticals Other
redalpine Basecamp Research

2024

Series B Biotechnology & Medical Research (NEC) Other
N/A Character Bio

2023

Series B Bio Therapeutic Drugs Other
Wellington Partners ImCheck Therapeutics

2019

Series B Bio Therapeutic Drugs Other

naturalX Health Ventures

invested in

Function Health

in 2025

in a Series B deal

Disclosed details

Transaction Size: $298M

Enterprise Value: $2,500M

Equity Value: $2,500M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert